Evidence map›Paper›PMID 28575361›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2017

Chest Radiograph Findings in Childhood Pneumonia Cases From the Multisite PERCH Study.

Nicholas Fancourt, Maria Deloria Knoll, Henry C Baggett, W Abdullah Brooks, Daniel R Feikin, Laura L Hammitt, Stephen R C Howie, Karen L Kotloff, Orin S Levine, Shabir A Madhi and 26 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 4 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 4 syntheses or guidelines pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

36 authors at 19 institutions in 11 countries.

Nicholas FancourtDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Maria Deloria KnollDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Henry C BaggettGlobal Disease Detection Center, Thailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi.
W Abdullah BrooksDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Daniel R FeikinDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Laura L HammittDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Stephen R C HowieMedical Research Council Unit, Basse, The Gambia.
Karen L KotloffDivision of Infectious Disease and Tropical Pediatrics, Department of Pediatrics, Center for Vaccine Development, Institute of Global Health, University of Maryland School of Medicine,Baltimore.
Orin S LevineDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Shabir A MadhiMedical Research Council, Respiratory and Meningeal Pathogens Research Unit and.
David R MurdochDepartment of Pathology, University Otago and.
J Anthony G ScottKenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi.
Donald M TheaCenter for Global Health and Development, Boston University School of Public Health, Massachusetts.
Juliet O AworiKenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi.
Breanna Barger-KamateDepartment of Pediatrics, Division of Emergency Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland.
James ChipetaDepartment of Paediatrics and Child Health, University of Zambia School of Medicine and.
Andrea N DeLucaDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Mahamadou DialloCentre pour le Développement des Vaccins (CVD-Mali), Bamako, Mali.
Amanda J DriscollDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Bernard E EbrukeMedical Research Council Unit, Basse, The Gambia.
Melissa M HigdonDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Yasmin JahanInternational Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka and Matlab.
Ruth A KarronDepartment of International Health, Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Nasreen MahomedMedical Research Council, Respiratory and Meningeal Pathogens Research Unit and.
David P MooreMedical Research Council, Respiratory and Meningeal Pathogens Research Unit and.
Kamrun NaharInternational Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka and Matlab.
Sathapana NaoratGlobal Disease Detection Center, Thailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi.
Micah Silaba OmindeKenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi.
Daniel E ParkDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Christine ProsperiDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Somwe Wa SomweDepartment of Paediatrics and Child Health, University of Zambia School of Medicine and.
Somsak ThamthitiwatGlobal Disease Detection Center, Thailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi.
Syed M A ZamanMedical Research Council Unit, Basse, The Gambia.
Scott L ZegerDepartment of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Katherine L O'BrienDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
PERCH Study Group
Johns Hopkins University · USKenya Medical Research Institute · KECenters for Disease Control and Prevention · USUniversity of the Witwatersrand · ZAInternational Centre for Diarrhoeal Disease Research · BDLondon School of Hygiene & Tropical Medicine · GBMinistry of Public Health · THUniversity Teaching Hospital · ZMBoston University · USGates Foundation · USMilken Institute · USRoyal Children's Hospital · AUUniversity of Auckland · NZUniversity of Maryland, Baltimore · USUniversity of Zambia · ZMCanterbury Health Laboratories · NZMRC Unit the Gambia · GMRespiratory and Meningeal Pathogens Research Unit · ZACentre Pour le Développement des Vaccins-Mali · ML

Funding

Medical Research Council MC_U190088478
6 · The paper itself

Abstract

BACKGROUND.: Chest radiographs (CXRs) are frequently used to assess pneumonia cases. Variations in CXR appearances between epidemiological settings and their correlation with clinical signs are not well documented. METHODS.: The Pneumonia Etiology Research for Child Health project enrolled 4232 cases of hospitalized World Health Organization (WHO)-defined severe and very severe pneumonia from 9 sites in 7 countries (Bangladesh, the Gambia, Kenya, Mali, South Africa, Thailand, and Zambia). At admission, each case underwent a standardized assessment of clinical signs and pneumonia risk factors by trained health personnel, and a CXR was taken that was interpreted using the standardized WHO methodology. CXRs were categorized as abnormal (consolidation and/or other infiltrate), normal, or uninterpretable. RESULTS.: CXRs were interpretable in 3587 (85%) cases, of which 1935 (54%) were abnormal (site range, 35%-64%). Cases with abnormal CXRs were more likely than those with normal CXRs to have hypoxemia (45% vs 26%), crackles (69% vs 62%), tachypnea (85% vs 80%), or fever (20% vs 16%) and less likely to have wheeze (30% vs 38%; all P < .05). CXR consolidation was associated with a higher case fatality ratio at 30-day follow-up (13.5%) compared to other infiltrate (4.7%) or normal (4.9%) CXRs. CONCLUSIONS.: Clinically diagnosed pneumonia cases with abnormal CXRs were more likely to have signs typically associated with pneumonia. However, CXR-normal cases were common, and clinical signs considered indicative of pneumonia were present in substantial proportions of these cases. CXR-consolidation cases represent a group with an increased likelihood of death at 30 days post-discharge.

Indexed as

Radiography, ThoracicAustraliaBangladeshChild HealthChild, PreschoolFemaleGambiaHumansInfantInfant, NewbornInternationalityKenyaMaleMaliPneumoniaPneumonia, Bacterial.chest radiographmortalitypediatricspneumoniasigns and symptoms

Identifiers

PMID28575361
PMCPMC5447837
OpenAlexW2617100200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.